No Data
No Data
Zura Bio Ltd (ZURA) Q1 2024 Earnings: Financial and Strategic Developments
Zura Bio Is Maintained at Outperform by Oppenheimer
Zura Bio Is Maintained at Outperform by Oppenheimer
Oppenheimer: Maintaining the Zura Bio (ZURA.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $16.00 to $21.00.
Oppenheimer: Maintaining the Zura Bio (ZURA.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $16.00 to $21.00.
Oppenheimer Adjusts Zura Bio Price Target to $21 From $16, Maintains Outperform Rating
Zura Bio (ZURA) has an average rating of Buy and price targets ranging from $10 to $26, according to analysts polled by Capital IQ. Price: 4.61, Change: +0.01, Percent Change: +0.11
Zura Bio Q1 2024 GAAP EPS $(0.02) Beats $(0.23) Estimate
Zura Bio (NASDAQ:ZURA) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.23) by 91.3 percent.
10-Q: Quarterly report
No Data